# EDGAR Filing Document

**Accession Number:** 0001823138
**File Stem:** 0001011438-25-000471
**Filing Date:** 2025-10
**Character Count:** 20644
**Document Hash:** bd7298c3b074e584395e86f4896daed4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001011438-25-000471.hdr.sgml**: 20251009

**ACCESSION NUMBER**: 0001011438-25-000471

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20251009

**DATE AS OF CHANGE**: 20251009

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Core Scientific, Inc./tx
- **CENTRAL INDEX KEY:** 0001839341
- **STANDARD INDUSTRIAL CLASSIFICATION:** FINANCE SERVICES [6199]
- **ORGANIZATION NAME:** 09 Crypto Assets
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92274
- **FILM NUMBER:** 251386118

**BUSINESS ADDRESS:**
- **STREET 1:** 838 WALKER ROAD
- **STREET 2:** SUITE 21-2105
- **CITY:** DOVER
- **STATE:** DE
- **ZIP:** 19904
- **BUSINESS PHONE:** (425) 998-5300

**MAIL ADDRESS:**
- **STREET 1:** 838 WALKER ROAD
- **STREET 2:** SUITE 21-2105
- **CITY:** DOVER
- **STATE:** DE
- **ZIP:** 19904

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Power & Digital Infrastructure Acquisition Corp.
- **DATE OF NAME CHANGE:** 20210106
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Two Seas Capital LP
- **CENTRAL INDEX KEY:** 0001823138

**ORGANIZATION NAME:**
- **EIN:** 843799363
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 32 ELM PLACE, 3RD FLOOR
- **CITY:** RYE
- **STATE:** NY
- **ZIP:** 10580
- **BUSINESS PHONE:** 917.536.6028

**MAIL ADDRESS:**
- **STREET 1:** 32 ELM PLACE, 3RD FLOOR
- **CITY:** RYE
- **STATE:** NY
- **ZIP:** 10580

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Kairos Capital Management LP
- **DATE OF NAME CHANGE:** 20200831

## Exhibit 99.1

#### TRANSACTIONS
The following table sets forth all transactions by the Reporting Persons (on behalf of the Funds or Accounts) with respect to the securities of Core Scientific, Inc. effected in the last 60 days, inclusive of any transactions effected through 4:00 p.m., New York City time, on October 9, 2025. Except as otherwise noted below, all such transactions were purchases or sales of securities of Core Scientific, Inc. effected in the open market, and the table excludes commissions paid in per share prices.

#### TWO SEAS GLOBAL (MASTER) FUND LP

---

| | | | |
|:---|:---|:---|:---|
| Type of Security | Amount Purchased/(Sold) | Price Per Security ($) or Contract\* | Date of Purchase/Sale |
| Common Stock | 402082 | 14.040 | 8/26/2025 |
| Common Stock | 100000 | 14.100 | 8/27/2025 |
| Common Stock | 250000 | 14.148 (1) | 8/27/2025 |
| Common Stock | 79279 | 13.790 | 9/2/2025 |
| Common Stock | 79279 | 13.799 (2) | 9/2/2025 |
| Common Stock | 118917 | 13.800 | 9/2/2025 |
| Common Stock | 100000 | 13.670 (3) | 9/3/2025 |
| Common Stock | (150000) | 14.760 | 9/9/2025 |
| Common Stock | 150000 | 15.827 (4) | 9/12/2025 |
| Common Stock | 100000 | 15.847 (5) | 9/12/2025 |
| Common Stock | 100000 | 16.800 | 9/19/2025 |
| Common Stock | 50000 | 16.860 | 9/19/2025 |
| Common Stock | 100000 | 16.860 | 9/19/2025 |
| Common Stock | 125000 | 17.017 (6) | 9/23/2025 |
| Common Stock | 75000 | 17.360 | 9/23/2025 |
| Common Stock | 100000 | 17.013 (7) | 9/24/2025 |
| Common Stock | 150000 | 17.935 | 10/1/2025 |
| Common Stock | 150000 | 17.893 (8) | 10/6/2025 |
| Common Stock | 140000 | 17.002 (9) | 10/7/2025 |
| Common Stock | 125000 | 17.120 (10) | 10/7/2025 |
| Common Stock | 200000 | 17.124 (11) | 10/7/2025 |

---

#### TWO SEAS STRATEGIC INVESTMENT FUND LP <br>

---

| | | | |
|:---|:---|:---|:---|
| Type of Security | Amount Purchased/(Sold) | Price Per Security ($) or Contract\* | Date of Purchase/Sale |
| Common Stock | 117873 | 13.709 | 8/13/2025 |
| Common Stock | 78798 | 14.000 | 8/29/2025 |
| Common Stock | 16328 | 13.790 | 9/2/2025 |
| Common Stock | 16328 | 13.799 (12) | 9/2/2025 |
| Common Stock | 24493 | 13.800 | 9/2/2025 |
| Common Stock | 118215 | 13.670 (13) | 9/3/2025 |
| Common Stock | 19680 | 17.017 (14) | 9/23/2025 |
| Common Stock | 56319 | 17.002 (15) | 10/7/2025 |

---

#### ACCOUNTS

---

| | | | |
|:---|:---|:---|:---|
| Type of Security | Amount Purchased/(Sold) | Price Per Security ($) or Contract\* | Date of Purchase/Sale |
| Common Stock | 22489 | 13.709 | 8/13/2025 |
| Common Stock | 9638 | 13.709 | 8/13/2025 |
| Common Stock | 14841 | 14.000 | 8/29/2025 |
| Common Stock | 6361 | 14.000 | 8/29/2025 |
| Common Stock | 3075 | 13.790 | 9/2/2025 |
| Common Stock | 3075 | 13.799 (16) | 9/2/2025 |
| Common Stock | 4613 | 13.800 | 9/2/2025 |
| Common Stock | 1318 | 13.790 | 9/2/2025 |
| Common Stock | 1318 | 13.799 (17) | 9/2/2025 |
| Common Stock | 1977 | 13.800 | 9/2/2025 |
| Common Stock | 22250 | 13.670 (18) | 9/3/2025 |
| Common Stock | 9535 | 13.670 (19) | 9/3/2025 |
| Common Stock | 3724 | 17.017 (20) | 9/23/2025 |
| Common Stock | 1596 | 17.017 (21) | 9/23/2025 |
| Common Stock | 2577 | 17.002 (22) | 10/7/2025 |
| Common Stock | 1104 | 17.002 (23) | 10/7/2025 |

---

(1) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.035 to $14.27, inclusive. The reporting persons undertake to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in footnotes (1) – (23).

(2) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.775 to $13.80, inclusive.

(3) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.45 to $13.75, inclusive.

(4) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.77 to $15.88, inclusive.

(5) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.775 to $15.88, inclusive.

(6) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.735 to $17.25, inclusive.

(7) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.94 to $17.05, inclusive.

(8) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.825 to $17.96, inclusive.

(9) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.91 to $17.415, inclusive.

(10) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.90 to $17.279, inclusive.

(11) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.07 to $17.25, inclusive.

(12) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.775 to $13.80, inclusive.

(13) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.45 to $13.75, inclusive.

(14) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.735 to $17.25, inclusive.

(15) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.91 to $17.415, inclusive.

(16) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.775 to $13.80, inclusive.

(17) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.775 to $13.80, inclusive.

(18) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.45 to $13.75, inclusive.

(19) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.45 to $13.75, inclusive.

(20) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.735 to $17.25, inclusive.

(21) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.735 to $17.25, inclusive.

(22) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.91 to $17.415, inclusive.

(23) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.91 to $17.415, inclusive.

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**Core Scientific, Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.00001 per share**

*(Title of Class of Securities)*

**21874A106**

*(CUSIP Number)*

**Lawrence V. Palermo**<br>Two Seas Capital LP<br>32 Elm Place, 3rd Floor<br>Rye NY 10580<br>(646) 420-4504

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**10/07/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **21874A106** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Two Seas Capital LP** | Name of reporting person<br>**Two Seas Capital LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**19902624.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**19902624.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**19902624.00** | Aggregate amount beneficially owned by each reporting person<br>**19902624.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**6.5%** | Percent of class represented by amount in Row (11)<br>**6.5%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IA** | Type of Reporting Person (See Instructions)<br>**IA** | |

---

| **CUSIP No.** | **21874A106** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Two Seas Capital GP LLC** | Name of reporting person<br>**Two Seas Capital GP LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**19902624.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**19902624.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**19902624.00** | Aggregate amount beneficially owned by each reporting person<br>**19902624.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**6.5%** | Percent of class represented by amount in Row (11)<br>**6.5%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**HC** | Type of Reporting Person (See Instructions)<br>**HC** | |

---

| **CUSIP No.** | **21874A106** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Sina Toussi** | Name of reporting person<br>**Sina Toussi** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**19902624.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**19902624.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**19902624.00** | Aggregate amount beneficially owned by each reporting person<br>**19902624.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**6.5%** | Percent of class represented by amount in Row (11)<br>**6.5%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.00001 per share

**(b) Name of Issuer:**
Core Scientific, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
838 Walker Road, 21-2105, Dover, DE, 19904

The following constitutes Amendment No. 1 ("Amendment No. 1") to the Schedule 13D filed with the Securities and Exchange Commission ("SEC") by Two Seas Capital LP ("TSC"), Two Seas Capital GP LLC ("TSC GP") and Sina Toussi (collectively, the "Reporting Persons") on August 8, 2025.  This Amendment No. 1 amends and supplements the Schedule 13D as specifically set forth herein.

All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable.

**Item 4. Purpose of Transaction**

Item 4 of this Schedule 13D is supplemented and superseded, as the case may be, as follows:

As previously disclosed, TSC has expressed its intent to vote against the adoption of the Merger Agreement at the upcoming Special Meeting and intends to solicit proxies against the Issuer's proposal to adopt the Merger Agreement at the Special Meeting.  The Reporting Persons filed their Definitive Proxy Statement with the Securities and Exchange Commission in connection with the Special Meeting on September 29, 2025.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Each of the Reporting Persons may be deemed to beneficially own 19,902,624 shares of Common Stock of the Issuer, which includes 313,646 shares of Common Stock issuable upon exercise of warrants and options to purchase 3,400,000 shares of Common Stock.  Such amount of beneficial ownership represents approximately 6.5% of the shares of Common Stock outstanding, based on 307,355,193 shares of Common Stock outstanding as of September 19, 2025, based on information disclosed in the Issuer's Proxy Statement filed with the Securities and Exchange Commission on September 26, 2025, plus 313,646 shares of Common Stock issuable upon the exercise of warrants held by the Funds.  The Funds and Accounts have delegated to TSC sole voting and investment power over the securities held by the Funds and Accounts pursuant to their respective Investment Management Agreements with TSC. As a result, each of TSC, TSC GP, as the general partner of TSC, and Mr. Toussi, as Chief Investment Officer of TSC and Managing Member of TSC GP, may be deemed to exercise voting and investment power over the securities of the Issuer directly held by the Funds and Accounts. The Funds and Accounts specifically disclaim beneficial ownership of the securities of the Issuer directly held by them by virtue of their inability to vote or dispose of such securities as a result of their respective Investment Management Agreements with TSC. The information in Item 3 regarding the securities held by the Funds and Accounts is incorporated herein by reference.

The options to purchase Common Stock consist of options to purchase 3,400,000 shares of Common Stock with an exercise price of $15 per share that expire on January 16, 2026.  Global Fund sold options to purchase 1,700,000 shares of Common Stock with an exercise price of $21 per share that expire on January 16, 2026.

Item 6 of this Schedule 13D is incorporated herein by reference.

**(b)**
Items 7 through 10 of each of the cover pages of this Schedule 13D are incorporated herein by reference. The information in Item 3 regarding the securities held by the Funds and Accounts is incorporated herein by reference.

**(c)**
Transactions by the Reporting Persons (on behalf of the Funds and Accounts) effected during the past 60 days are set forth in Exhibit 99.1 and such information is incorporated herein by reference.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Item 6 of this Schedule 13D is supplemented and superseded, as the case may be, as follows:

Item 5 of this Schedule 13D is incorporated herein by reference.

The Global Fund no longer has any cash-settled swaps positions.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Two Seas Capital LP

**Signature:** /s/ Sina Toussi

**Name/Title:** Sina Toussi/Managing Member of Two Seas Capital GP LLC, its general partner

**Date:** 10/09/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Two Seas Capital GP LLC

**Signature:** /s/ Sina Toussi

**Name/Title:** Sina Toussi/Managing Member

**Date:** 10/09/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Sina Toussi

**Signature:** /s/ Sina Toussi

**Name/Title:** Sina Toussi/Self

**Date:** 10/09/2025